International Clinical Trial: Phase 1 Randomised, Double-Blind, Placebo-Controlled Study Assessing the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of OV4071 in Healthy Participants

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ACTRN12626000480381) titled 'Phase 1 Randomised, Double-Blind, Placebo-Controlled Study Assessing the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of OV4071 in Healthy Participants' on April 17.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial

Primary Sponsor: Ovid Therapeutics Australia Pty Ltd

Condition: Parkinson's disease Parkinson's disease Neurological - Parkinson's disease

Intervention: The study will be a Phase 1, single- center, randomized, double-blind, parallel, placebo controlled, inpatient study of the safety and tolerability o...